{"log_id": 3305208875346755960, "direction": 0, "words_result_num": 22, "words_result": [{"probability": {"variance": 8.3e-05, "average": 0.995917, "min": 0.957784}, "location": {"width": 544, "top": 193, "height": 40, "left": 196}, "words": "单用二甲双胍血糖控制不佳而加用西格列汀的患者:"}, {"probability": {"variance": 4e-05, "average": 0.997647, "min": 0.961655}, "location": {"width": 838, "top": 235, "height": 47, "left": 198}, "words": "两项纳入2型糖尿病患者的双盲、安慰剂对照临床试验,旨在评估西格列汀和二"}, {"probability": {"variance": 0.001469, "average": 0.988902, "min": 0.778228}, "location": {"width": 838, "top": 283, "height": 46, "left": 199}, "words": "甲双胍联合治疗的疗效和安全性。在这两项试验中,服用剂量≥1500mg/日二甲"}, {"probability": {"variance": 0.000361, "average": 0.994869, "min": 0.884872}, "location": {"width": 838, "top": 331, "height": 47, "left": 203}, "words": "双胍后血糖仍控制不佳的患者被随机分组,在已有的二甲双胍治疗基础上分别加"}, {"probability": {"variance": 0.000381, "average": 0.988031, "min": 0.93805}, "location": {"width": 317, "top": 389, "height": 32, "left": 202}, "words": "服西格列汀100mg/天或安慰剂"}, {"probability": {"variance": 0.000312, "average": 0.99466, "min": 0.887474}, "location": {"width": 838, "top": 468, "height": 46, "left": 204}, "words": "其中一项试验纳入701例患者,分别接受100mg西格列汀或安慰剂每日一次的治疗"}, {"probability": {"variance": 0.002453, "average": 0.977733, "min": 0.774779}, "location": {"width": 840, "top": 516, "height": 44, "left": 205}, "words": "共24周。与二甲双胍十安慰剂组相比,二甲双胍十西格列汀组患者的HbA1e"}, {"probability": {"variance": 0.000621, "average": 0.988276, "min": 0.836628}, "location": {"width": 829, "top": 563, "height": 45, "left": 216}, "words": "(0.65%)、空腹血糖(-25.4mg/dL)以及餐后两小时血糖(-50.6mg/dL)都有明"}, {"probability": {"variance": 0.00073, "average": 0.989983, "min": 0.864086}, "location": {"width": 838, "top": 610, "height": 45, "left": 207}, "words": "显的改善。(参见图1和表4)。与安慰剂相比,HbA1c的这种改善不受以下因素"}, {"probability": {"variance": 0.000489, "average": 0.993621, "min": 0.875978}, "location": {"width": 840, "top": 658, "height": 44, "left": 207}, "words": "的影响,包括:基线 Hbalc值、既往降糖治疗、性别、年龄、基线BMI、糖尿病"}, {"probability": {"variance": 0.020587, "average": 0.94352, "min": 0.364887}, "location": {"width": 839, "top": 705, "height": 45, "left": 210}, "words": "确诊时间、是否合并代谢综合征、胰岛素抵抗(HOMA-R)或胰岛素分泌"}, {"probability": {"variance": 0.001214, "average": 0.983796, "min": 0.841014}, "location": {"width": 812, "top": 752, "height": 45, "left": 235}, "words": "HOMA-B)的标准指数。与服用安慰剂的患者相比,服用西格列汀的患者的总"}, {"probability": {"variance": 0.000377, "average": 0.990166, "min": 0.907964}, "location": {"width": 838, "top": 799, "height": 44, "left": 210}, "words": "胆固醇、非HDL胆固醇和甘油三酯显示有轻微下降,两组患者体重下降的程度相"}, {"probability": {"variance": 0, "average": 0.999994, "min": 0.999994}, "location": {"width": 29, "top": 861, "height": 28, "left": 211}, "words": "近"}, {"probability": {"variance": 0.001196, "average": 0.991481, "min": 0.789037}, "location": {"width": 835, "top": 895, "height": 42, "left": 213}, "words": "图1:2型糖尿病患者接受二甲双胍+每日总剂量100mg的西格列汀或安慰剂"}, {"probability": {"variance": 0.008513, "average": 0.97126, "min": 0.555991}, "location": {"width": 484, "top": 945, "height": 35, "left": 384}, "words": "二甲双胍治疗24周后,HbA1e较基线时的变化"}, {"probability": {"variance": 0.036538, "average": 0.701863, "min": 0.441554}, "location": {"width": 26, "top": 1067, "height": 196, "left": 393}, "words": "兰以软计条"}, {"probability": {"variance": 0, "average": 0.99998, "min": 0.99998}, "location": {"width": 22, "top": 1346, "height": 22, "left": 683}, "words": "周"}, {"probability": {"variance": 0.025105, "average": 0.85992, "min": 0.531287}, "location": {"width": 209, "top": 1378, "height": 25, "left": 467}, "words": "格列汀十二甲双治疗组"}, {"probability": {"variance": 0.030682, "average": 0.887431, "min": 0.372733}, "location": {"width": 215, "top": 1373, "height": 28, "left": 728}, "words": "安慰剂十二甲双胍治疗组"}, {"probability": {"variance": 4e-06, "average": 0.99885, "min": 0.992423}, "location": {"width": 409, "top": 1435, "height": 38, "left": 242}, "words": "二甲双胍单药治疗血糖控制不佳的患者"}, {"probability": {"variance": 0.000296, "average": 0.995626, "min": 0.901018}, "location": {"width": 775, "top": 1474, "height": 48, "left": 233}, "words": "校正既往降糖治疗和基线值后所有接受治疗患者的最小二乘法调整平均数"}], "language": 3}